Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Solving Kids' Cancer
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Shop Contact us Donate
Menu
  • About us
    • What we do
    • Meet the team
      • Trustees
      • Our team
    • Patron
    • Parent Involvement Forum
    • Join our Team
    • Annual reports
  • About neuroblastoma
    • What is neuroblastoma?
    • Symptoms
    • Diagnosis
    • Neuroblastoma treatment
  • Support
    • Family support
    • Access treatment
    • Neuroblastoma Parent Education Conference
      • Neuroblastoma Parent Global Symposium 2020
      • See past conferences
    • Other sources of help
  • Research
    • Our research
    • Scientific Advisory Board
    • Funding award process
    • Projects
    • Funding partners
    • Research policies
    • Research blog
  • Support Our Work
    • Donate now
    • Shop
    • Ambassador Programme
    • Corporate partnerships
    • Challenge events
    • Set up a fundraising page
    • Fundraising resources
  • Children’s stories
    • Stories
    • Children’s campaigns
    • In memory
    • Named funds
  • News
    • News
    • Blogs
  • Admin
    • Log in
  • Basket: (0 items)
  • Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

    Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

    In a landmark in paediatric oncology research, children with high-risk neuroblastoma across Europe and North America will be treated together for the first time. Read more

  • Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

    Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

    Grant Award - High-Risk Neuroblastoma Clinical Trial 2 Read more

  • Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities
  • Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021
  • Next
  • Prev
  1. Research
  2. Projects

Research projects

Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

In a landmark in paediatric oncology research, children with high-risk neuroblastoma across Europe and North America will be treated together for the first time. Read more

Published: 6th November, 2020

Updated: 10th December, 2020

Author: Anne Denman

Related topics:
  • Research projects
Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

Grant awarded to open SIOPEN High-Risk Neuroblastoma Clinical Trial 2 across the UK in 2021

Grant Award - High-Risk Neuroblastoma Clinical Trial 2 Read more

Published: 19th May, 2020

Author: Anne Denman

Related topics:
  • Research projects
Grant awarded to identify markers of poor survival in high-risk neuroblastoma

Grant awarded to identify markers of poor survival in high-risk neuroblastoma

Solving Kids’ Cancer Europe, Solving Kids' Cancer in New York, Oscar Knox Fund and Merryn Lacy Trust have awarded a grant of $420,000 to co-investigators. Read more

Published: 18th November, 2019

Updated: 7th December, 2020

Author: Anne Denman

Related topics:
  • Research projects
Lorlatinib (PF-06463922) : Third-generation ALK inhibitor

Lorlatinib (PF-06463922) : Third-generation ALK inhibitor

This exciting new clinical trial sees 17 transatlantic centres in the UK, USA and Europe, recruiting patients simultaneously for an innovative new third-generation ALK-inhibitor agent lorlatinib (PF-06463922). Read more

Published: 3rd September, 2019

Updated: 14th October, 2019

Author: Kavita Naidu

Related topics:
  • Research projects
National Neuroblastoma Genetics Reference Centre

National Neuroblastoma Genetics Reference Centre

The National Neuroblastoma Genetics Reference Centre aims to provide a comprehensive service genetic characterisation of all neuroblastoma tumours at diagnosis and a subset at relapse. Read more

Published: 12th June, 2019

Updated: 20th August, 2019

Author: Kavita Naidu

Related topics:
  • Research projects
Biomarker evaluation of neuroblastoma mRNAs in children enrolled in the BEACON trial

Biomarker evaluation of neuroblastoma mRNAs in children enrolled in the BEACON trial

In this study, blood and bone marrow samples from 120 children treated in the BEACON-Neuroblastoma trial will be collected in order to analyse levels of neuroblastoma mRNAs Read more

Published: 12th June, 2019

Updated: 20th August, 2019

Author: Kavita Naidu

Related topics:
  • Research projects
MiNivAn : Phase I study of I-131 MIBG, nivolumab and ch14.18/CHO

MiNivAn : Phase I study of I-131 MIBG, nivolumab and ch14.18/CHO

MiNivAn aims to improve the cure rate of children with relapsed or refractory neuroblastoma by combining targeted radiotherapy (I-131 MIBG) with the antibodies anti-GD2 (ch14.18/CHO) and anti-PD1 (nivolumab). Read more

Published: 12th June, 2019

Updated: 20th August, 2019

Author: Kavita Naidu

Related topics:
  • Research projects

Neuroblastoma Senior Trials Coordinator

Solving Kids’ Cancer funds a dedicated Senior Trials Coordinator for Neuroblastoma within the Children’s Cancer Trials Team (CCTU) of the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham. Read more

Published: 11th June, 2019

Updated: 19th May, 2020

Author: Kavita Naidu

Related topics:
  • Research projects
PTPP – ITCC-P4 Collaboration

PTPP – ITCC-P4 Collaboration

Bringing together American NCI PPTC and European ITCC-P4 paediatric preclinical research consortiums together for the first time ever via the Pediatric Cancer Working Group at the AACR Annual Meeting. Read more

Published: 11th June, 2019

Updated: 20th August, 2019

Author: Kavita Naidu

Related topics:
  • Research projects
BEACON Immuno (anti-GD2 amendment)

BEACON Immuno (anti-GD2 amendment)

The BEACON study is a chemotherapy and antibody combination trial. Read more

Published: 11th June, 2019

Updated: 19th August, 2019

Author: Kavita Naidu

Related topics:
  • Research projects
International Neuroblastoma Research Initiative 2018

International Neuroblastoma Research Initiative 2018

Solving Kids’ Cancer is leading an international competitive funding call commencing with a Request for Applications (RFA) Read more

Published: 11th June, 2019

Updated: 8th November, 2019

Author: Kavita Naidu

Related topics:
  • Research projects
International Research Initiative 2019

International Research Initiative 2019

Solving Kids’ Cancer has issued a joint 2019 International Challenge Grant Call for GBP 500,000 awarded over three years Read more

Published: 14th October, 2018

Updated: 17th October, 2019

Author: Nick Pryce

Related topics:
  • Research projects
Back to top

Showing 10 of 12

Latest

  • 100 miles for Henry In March

    100 miles for Henry In March

    Henry is such a strong an amazing little boy, a real inspiration at such a young age. I want to try and help him and his family reach their goal to continue his treatment.

  • Karen and Evie’s 23 day Squatty Botty

    Karen and Evie’s 23 day Squatty Botty

    We are taking on the Squatty Botty challenge to raise much needed funds for dear little Ollie

  • Leeanne Brennan

  • A Half Marathon for Henry The Brave

    A Half Marathon for Henry The Brave

    Henry has high-risk neuroblastoma, an aggressive childhood cancer that has a 40-50% chance of long-term survival at diagnosis. His family need support for his on going treatment.

Most read

  • Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.

  • Corey is thriving after neuroblastoma battle

    Corey is thriving after neuroblastoma battle

    Family donate almost £150,000 to neuroblastoma research

  • Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Alexandra Lane was formally voted on and welcomed to our Board of Trustees this week. We are thrilled to welcome Alex to the team.

  • BEACON study opens in Europe

    BEACON study opens in Europe

    The much-anticipated BEACON study amendment is now open and recruiting patients.

  • Steve Richards to step down as Chief Executive

    Steve Richards to step down as Chief Executive

    CEO to leave Solving Kids' Cancer after three years in the role.

  • Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.

  • Charities fund new clinical trial

    Charities fund new clinical trial

    Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

  • First Three Months

    First Three Months

    Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.

  • Ewen's Journey

    Ewen's Journey

    Ewen sadly passed away on 28th September 2020.

  • Neuroblastoma Parent Global Symposium 2020

    Neuroblastoma Parent Global Symposium 2020

    Neuroblastoma Parent Global Symposium 2020

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Contact us

Solving Kids' Cancer UK
Coram Campus
41 Brunswick Square
London
WC1N 1AZ

Phone: 020 7284 0800

Follow us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn

  • Jobs
  • Media enquiries
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Safeguarding Statement
  • Privacy Policy

Solving Kids’ Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208648). The charity and company is currently operating as Solving Kids’ Cancer.